Loretta Jacques

2.9k citations

69 papers · 2.0k · 2 hit papers · h-index 21

Impact in

Physiology top 1%
- Asthma and respiratory diseases
Pulmonary and Respiratory Medicine top 1%
- Respiratory and Cough-Related Research
- Inhalation and Respiratory Drug Delivery
- Chronic Obstructive Pulmonary Disease (COPD) Research

Papers in

Physiology 61
- Asthma and respiratory diseases 61
Pulmonary and Respiratory Medicine 51
- Respiratory and Cough-Related Research 42
- Inhalation and Respiratory Drug Delivery 32
- Chronic Obstructive Pulmonary Disease (COPD) Research 10

Co-authors: N Ringdal (1 shared paper)Ann J. Woolcock (1 shared paper)Bo Lundbäck (1 shared paper)Eric D. Bateman (30 shared papers)Ashley Woodcock (34 shared papers)Jan Lötvall (27 shared papers)Eugene R. Bleecker (24 shared papers)Paul M. O’Byrne (19 shared papers)
Journals: Journal of Asthma (8 papers)Respiratory Medicine (8 papers)Respiratory Research (4 papers)Thorax (3 papers)Gastroenterology (3 papers)
Partner nations: United Kingdom United States South Africa

In The Last Decade

Loretta Jacques

68 papers receiving 1.9k citations

Loretta Jacques's Hit Papers

align trajectories log scale

Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotype 2024 · 47 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2024 New England Journal of Medicine
1996 American Journal of Respiratory and Critical Care Medicine

Peers

Countries citing papers authored by Loretta Jacques

Since Specialization

Citations

This map shows the geographic impact of Loretta Jacques's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Loretta Jacques with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Loretta Jacques more than expected).

Fields of papers citing papers by Loretta Jacques

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Loretta Jacques. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Loretta Jacques. The network helps show where Loretta Jacques may publish in the future.

Co-authors

The 25 scholars most cited alongside Loretta Jacques, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Loretta Jacques Line = papers co-authored together Loretta Jacques links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 69 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Comparison of Addition of Salmeterol to Inhaled Steroids With Doubling of the Dose of Inhaled Steroids American Journal of Respiratory and Critical Care Medicine ·Ann J. Woolcock, Bo Lundbäck, N Ringdal, Loretta Jacques Hit paper breakdown →	1996	569
2	A factor from neurons increases the number of acetylcholine receptor aggregates on cultured muscle cells. Proceedings of the National Academy of Sciences ·C. N. Christian, Mathew P. Daniels, Hiroyuki Sugiyama, Z. Vogel, Loretta Jacques, P. G. Nelson	1978	154
3	Asthma control can be maintained when fluticasone propionate/salmeterol in a single inhaler is stepped down Journal of Allergy and Clinical Immunology ·Eric D. Bateman, Loretta Jacques, Caroline Goldfrad, Tito Atienza, Triaian Mihaescu, Marie T. Duggan	2006	75
4	Efficacy and Safety of Fluticasone Furoate/Vilanterol Compared With Fluticasone Propionate/Salmeterol Combination in Adult and Adolescent Patients With Persistent Asthma CHEST Journal ·Ashley Woodcock, Eugene R. Bleecker, Jan Lötvall, Paul M. O’Byrne, Eric D. Bateman, Hilary Medley, Anna Ellsworth, Loretta Jacques, (unknown)	2013	73
5	Fluticasone furoate demonstrates efficacy in patients with asthma symptomatic on medium doses of inhaled corticosteroid therapy: an 8-week, randomised, placebo-controlled trial Thorax ·William W. Busse, Eugene R. Bleecker, Eric D. Bateman, Jan Lötvall, Richard Forth, Angela Davis, Loretta Jacques, Brett Haumann, Ashley Woodcock	2011	67
6	Once-daily fluticasone furoate alone or combined with vilanterol in persistent asthma European Respiratory Journal ·Paul M. O’Byrne, Eugene R. Bleecker, Eric D. Bateman, (unknown), Ashley Woodcock, Richard Forth, William T. Toler, Loretta Jacques, Jan Lötvall	2013	65
7	A placebo‐controlled study of fluticasone propionate aqueous nasal spray and beclomethasone dipropionate in perennial rhinitis: efficacy in allergic and non‐allergic perennial rhinitis Clinical & Experimental Allergy ·G. K. Scadding, Valerie J. Lund, Loretta Jacques, D. H. Richards	1995	64
8	Once-daily fluticasone furoate (FF)/vilanterol reduces risk of severe exacerbations in asthma versus FF alone Thorax ·Eric D. Bateman, Paul M. O’Byrne, (unknown), Jan Lötvall, Eugene R. Bleecker, Leslie Andersen, Loretta Jacques, Lucy Frith, Jessica Lim, Ashley Woodcock	2013	61
9	24-h duration of the novel LABA vilanterol trifenatate in asthma patients treated with inhaled corticosteroids European Respiratory Journal ·Jan Lötvall, Eric D. Bateman, Eugene R. Bleecker, William W. Busse, Ashley Woodcock, Richard Follows, Jessica Lim, Sally Stone, Loretta Jacques, Brett Haumann	2012	61
10	Dose effect of once-daily fluticasone furoate in persistent asthma: A randomized trial Respiratory Medicine ·Eric D. Bateman, Eugene R. Bleecker, Jan Lötvall, Ashley Woodcock, Richard Forth, Hilary Medley, Angela Davis, Loretta Jacques, Brett Haumann, (unknown)	2012	57
11	Safety and tolerability of the novel inhaled corticosteroid fluticasone furoate in combination with the β₂agonist vilanterol administered once daily for 52 weeks in patients ≥12 years old with asthma: a randomised trial Thorax ·(unknown), Paul M. O’Byrne, Eugene R. Bleecker, Jan Lötvall, Ashley Woodcock, Leslie Andersen, Wesley L. Hicks, Jodie Crawford, Loretta Jacques, Ludovic Apoux, Eric D. Bateman	2013	56
12	Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotype New England Journal of Medicine ·David J. Jackson, Michael E. Wechsler, Daniel J. Jackson, David I. Bernstein, Stephanie Korn, Paul Pfeffer, Ruchong Chen, Junpei Saito, Gustavo de Luíz Martinez, Lucyna Dymek, Loretta Jacques, Nicholas Bird, Stein Schalkwijk, Douglas G. Smith, Peter Howarth, Ian Pavord Hit paper breakdown →	2024	47
13	Once-daily fluticasone furoate is efficacious in patients with symptomatic asthma on low-dose inhaled corticosteroids Annals of Allergy Asthma & Immunology ·Eugene R. Bleecker, Eric D. Bateman, (unknown), Ashley Woodcock, Lucy Frith, Karen House, Loretta Jacques, Angela Davis, Brett Haumann, Jan Lötvall	2012	45
14	Characterization and partial purification of a neuronal factor which increases acetylcholine receptor aggregation on cultured muscle cells Brain Research ·H. Bauer, Mathew P. Daniels, Paul A. Pudimat, Loretta Jacques, Hiroyuki Sugiyama, C. N. Christian	1981	43
15	Fluticasone Furoate–Vilanterol 100-25 mcg Compared with Fluticasone Furoate 100 mcg in Asthma: A Randomized Trial The Journal of Allergy and Clinical Immunology In Practice ·Eugene R. Bleecker, Jan Lötvall, Paul M. O’Byrne, Ashley Woodcock, (unknown), Edward Kerwin, Richard Forth, Hilary Medley, Carol Nunn, Loretta Jacques, Eric D. Bateman	2014	39
16	Fluticasone furoate: once-daily evening treatment versus twice-daily treatment in moderate asthma Respiratory Research ·Ashley Woodcock, Eugene R. Bleecker, (unknown), Jan Lötvall, Neil G. Snowise, Lucy Frith, Loretta Jacques, Brett Haumann, Eric D. Bateman	2011	38
17	Efficacy in asthma of once-daily treatment with fluticasone furoate: a randomized, placebo-controlled trial Respiratory Research ·Ashley Woodcock, Eric D. Bateman, (unknown), Jan Lötvall, Neil G. Snowise, Richard Forth, Loretta Jacques, Brett Haumann, Eugene R. Bleecker	2011	38
18	Fluticasone furoate (FF)/vilanterol (100/25 mcg or 200/25 mcg) or FF (100 mcg) in persistent asthma Journal of Asthma ·David I. Bernstein, Eric D. Bateman, Ashley Woodcock, William T. Toler, Richard Forth, Loretta Jacques, Carol Nunn, Paul M. O’Byrne	2015	37
19	Inhaled fluticasone furoate/vilanterol does not affect hypothalamic‐pituitary‐adrenal axis function in adolescent and adult asthma: randomised, double‐blind, placebo‐controlled study The Clinical Respiratory Journal ·Ann Allen, Isabelle Schenkenberger, Roopa Trivedi, Jeremy Cole, Wesley L. Hicks, Nadeem Gul, Loretta Jacques	2013	32
20	Efficacy and safety of fluticasone furoate 100 μg once-daily in patients with persistent asthma: A 24-week placebo and active-controlled randomised trial Respiratory Medicine ·Jan Lötvall, Eugene R. Bleecker, (unknown), Paul M. O’Byrne, Ashley Woodcock, Edward Kerwin, Sally Stone, Richard Forth, Loretta Jacques, Eric D. Bateman	2013	31

About Loretta Jacques

Loretta Jacques is a scholar working on Physiology, Pulmonary and Respiratory Medicine, Animal Science and Zoology, Immunology and Allergy and Molecular Biology, having authored 69 papers that have together received 2.0k indexed citations. Recurring topics across this work include Asthma and respiratory diseases (61 papers), Respiratory and Cough-Related Research (42 papers), Inhalation and Respiratory Drug Delivery (32 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (10 papers), Pharmacological Effects and Assays (8 papers), Allergic Rhinitis and Sensitization (5 papers), Ion channel regulation and function (2 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). The work is most often cited by research in Physiology (1.7k citations), Pulmonary and Respiratory Medicine (1.6k citations), Immunology and Allergy (208 citations), Animal Science and Zoology (102 citations) and Cellular and Molecular Neuroscience (144 citations). Loretta Jacques has collaborated with scholars based in United Kingdom, United States and South Africa. Frequent co-authors include N Ringdal, Ann J. Woolcock, Bo Lundbäck, Eric D. Bateman, Ashley Woodcock, Jan Lötvall, Eugene R. Bleecker, Paul M. O’Byrne, Richard Forth and Brett Haumann. Their work appears in journals such as Journal of Asthma, Respiratory Medicine, Respiratory Research, Thorax and Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Loretta Jacques

Impact in

Papers in i

In The Last Decade

Loretta Jacques

Loretta Jacques's Hit Papers

Peers

Countries citing papers authored by Loretta Jacques

Fields of papers citing papers by Loretta Jacques

All Works

About Loretta Jacques

Explore authors with similar magnitude of impact

Papers in